Insmed, Inc. (INSM)
176.27
-1.61
(-0.91%)
USD |
NASDAQ |
Dec 29, 16:00
177.61
+1.34
(+0.76%)
After-Hours: 18:01
Insmed Total Liabilities (Quarterly): 1.415B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Biogen, Inc. | 11.00B |
| Pfizer Inc. | 115.64B |
| Nektar Therapeutics | 216.26M |
| CorMedix, Inc. | 376.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.361B |
| Shareholders Equity (Quarterly) | 945.57M |
| Debt to Equity Ratio | 0.788 |
| Current Ratio | 4.630 |
| Net Debt Paydown Yield | 0.41% |